I recently constructed a full-length model of protein using multiple templates. Is there occurs any possible impact on inhibitor binding at active site by using either a truncated model (model of domain) or a full length model? I mean, are the the structures of the terminals of the protein may have potential impact on inhibitor binding on domain?

More Shishir K Gupta's questions See All
Similar questions and discussions